Ligand Pharmaceuticals | LGND - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Agenus USD 642K 399K 2025-09
Amgen USD 1.79B 128M 2025-12
Anika Therapeutics USD 11.44M 797K 2025-12
Baxter International USD 2.4B 512M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Enviri Corporation USD 472M 17.65M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 3.32B 531M 2025-12
Pacira USD 54.62M 6.02M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 39.28M 1.93M 2025-12